OTCMKTS:WWHC

W World Competitors

$6.09

+0.29 (+5.00 %)

(As of 04/8/2021 03:03 PM ET)

Add

Compare

Today's Range

$2.10

Now: $6.09▼

$6.10

50-Day Range

$2.30

MA: $3.81▼

$6.09

52-Week Range

$1.00

Now: $6.09▼

$27.40

Volume1,231 shs

Average Volume426 shs

Market Capitalization$1.80 million

P/E RatioN/A

Dividend YieldN/A

Beta1.97

W World (OTCMKTS:WWHC) Vs. PVTTF, KAYS, IPCIF, ISCO, BCTXF, and WCUI

Should you be buying WWHC stock or one of its competitors? Companies in the industry of "pharmaceutical preparations" are considered alternatives and competitors to W World, including Pivotal Therapeutics (PVTTF), Kaya (KAYS), Intellipharmaceutics International (IPCIF), International Stem Cell (ISCO), BriaCell Therapeutics (BCTXF), and Wellness Center USA (WCUI).

W World vs. Pivotal Therapeutics Stock

Pivotal Therapeutics (OTCMKTS:PVTTF) and W World (OTCMKTS:WWHC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Risk & Volatility

Pivotal Therapeutics has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, W World has a beta of 1.97, suggesting that its stock price is 97% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Pivotal Therapeutics and W World, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pivotal Therapeutics	0	0	0	0	N/A
W World	0	0	0	0	N/A

Insider and Institutional Ownership

0.1% of W World shares are owned by institutional investors. 61.1% of W World shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Pivotal Therapeutics and W World's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pivotal Therapeutics	N/A	N/A	N/A
W World	N/A	N/A	N/A

Valuation and Earnings

This table compares Pivotal Therapeutics and W World's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pivotal Therapeutics	N/A	N/A	N/A	N/A	N/A
W World	N/A	N/A	N/A	N/A	N/A

Summary

W World beats Pivotal Therapeutics on 3 of the 3 factors compared between the two stocks.

W World vs. Kaya Stock

Kaya (OTCMKTS:KAYS) and W World (OTCMKTS:WWHC) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Valuation and Earnings

This table compares Kaya and W World's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kaya	$1.01 million	6.21	$7.80 million	N/A	N/A
W World	N/A	N/A	N/A	N/A	N/A

Kaya has higher revenue and earnings than W World.

Profitability

This table compares Kaya and W World's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kaya	-1,558.07%	N/A	-586.93%
W World	N/A	N/A	N/A

Risk & Volatility

Kaya has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500. Comparatively, W World has a beta of 1.97, suggesting that its stock price is 97% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Kaya and W World, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kaya	0	1	0	0	2.00
W World	0	0	0	0	N/A

Insider and Institutional Ownership

Summary

W World beats Kaya on 5 of the 6 factors compared between the two stocks.

W World vs. Intellipharmaceutics International Stock

Intellipharmaceutics International (OTCMKTS:IPCIF) and W World (OTCMKTS:WWHC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Earnings and Valuation

This table compares Intellipharmaceutics International and W World's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intellipharmaceutics International	$3.48 million	1.60	$-8,090,000.00	N/A	N/A
W World	N/A	N/A	N/A	N/A	N/A

W World has lower revenue, but higher earnings than Intellipharmaceutics International.

Profitability

This table compares Intellipharmaceutics International and W World's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intellipharmaceutics International	-232.11%	N/A	-81.71%
W World	N/A	N/A	N/A

Risk and Volatility

Intellipharmaceutics International has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, W World has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for Intellipharmaceutics International and W World, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intellipharmaceutics International	0	0	0	0	N/A
W World	0	0	0	0	N/A

Institutional & Insider Ownership

0.1% of W World shares are held by institutional investors. 61.1% of W World shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

W World beats Intellipharmaceutics International on 5 of the 6 factors compared between the two stocks.

W World vs. International Stem Cell Stock

International Stem Cell (OTCMKTS:ISCO) and W World (OTCMKTS:WWHC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Earnings and Valuation

This table compares International Stem Cell and W World's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Stem Cell	$9.47 million	0.58	$-4,260,000.00	N/A	N/A
W World	N/A	N/A	N/A	N/A	N/A

W World has lower revenue, but higher earnings than International Stem Cell.

Profitability

This table compares International Stem Cell and W World's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
International Stem Cell	-55.56%	N/A	-72.21%
W World	N/A	N/A	N/A

Risk and Volatility

International Stem Cell has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, W World has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for International Stem Cell and W World, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
International Stem Cell	0	0	0	0	N/A
W World	0	0	0	0	N/A

Institutional & Insider Ownership

0.1% of W World shares are held by institutional investors. 81.7% of International Stem Cell shares are held by insiders. Comparatively, 61.1% of W World shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

W World beats International Stem Cell on 4 of the 6 factors compared between the two stocks.

W World vs. BriaCell Therapeutics Stock

BriaCell Therapeutics (OTCMKTS:BCTXF) and W World (OTCMKTS:WWHC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Earnings and Valuation

This table compares BriaCell Therapeutics and W World's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BriaCell Therapeutics	N/A	N/A	$-3,680,000.00	N/A	N/A
W World	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares BriaCell Therapeutics and W World's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BriaCell Therapeutics	N/A	N/A	-786.77%
W World	N/A	N/A	N/A

Risk and Volatility

BriaCell Therapeutics has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, W World has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for BriaCell Therapeutics and W World, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BriaCell Therapeutics	0	0	0	0	N/A
W World	0	0	0	0	N/A

Institutional & Insider Ownership

0.1% of BriaCell Therapeutics shares are held by institutional investors. Comparatively, 0.1% of W World shares are held by institutional investors. 61.1% of W World shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

W World beats BriaCell Therapeutics on 4 of the 4 factors compared between the two stocks.

W World vs. Wellness Center USA Stock

Wellness Center USA (OTCMKTS:WCUI) and W World (OTCMKTS:WWHC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Earnings and Valuation

This table compares Wellness Center USA and W World's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellness Center USA	$30,000.00	136.93	$-2,390,000.00	N/A	N/A
W World	N/A	N/A	N/A	N/A	N/A

W World has lower revenue, but higher earnings than Wellness Center USA.

Risk and Volatility

Wellness Center USA has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, W World has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.

Profitability

This table compares Wellness Center USA and W World's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Wellness Center USA	N/A	N/A	-1,809.19%
W World	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent recommendations for Wellness Center USA and W World, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellness Center USA	0	0	0	0	N/A
W World	0	0	0	0	N/A

Institutional & Insider Ownership

0.1% of Wellness Center USA shares are held by institutional investors. Comparatively, 0.1% of W World shares are held by institutional investors. 14.1% of Wellness Center USA shares are held by insiders. Comparatively, 61.1% of W World shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

W World beats Wellness Center USA on 4 of the 5 factors compared between the two stocks.